Literature DB >> 25878282

A new CRB1 rat mutation links Müller glial cells to retinal telangiectasia.

Min Zhao1, Charlotte Andrieu-Soler1, Laura Kowalczuk1, María Paz Cortés2, Marianne Berdugo1, Marilyn Dernigoghossian1, Francisco Halili3, Jean-Claude Jeanny1, Brigitte Goldenberg1, Michèle Savoldelli1, Mohamed El Sanharawi1, Marie-Christine Naud1, Wilfred van Ijcken4, Rosanna Pescini-Gobert5, Danielle Martinet6, Alejandro Maass2, Jan Wijnholds7, Patricia Crisanti1, Carlo Rivolta5, Francine Behar-Cohen8.   

Abstract

We have identified and characterized a spontaneous Brown Norway from Janvier rat strain (BN-J) presenting a progressive retinal degeneration associated with early retinal telangiectasia, neuronal alterations, and loss of retinal Müller glial cells resembling human macular telangiectasia type 2 (MacTel 2), which is a retinal disease of unknown cause. Genetic analyses showed that the BN-J phenotype results from an autosomal recessive indel novel mutation in the Crb1 gene, causing dislocalization of the protein from the retinal Müller glia (RMG)/photoreceptor cell junction. The transcriptomic analyses of primary RMG cultures allowed identification of the dysregulated pathways in BN-J rats compared with wild-type BN rats. Among those pathways, TGF-β and Kit Receptor Signaling, MAPK Cascade, Growth Factors and Inflammatory Pathways, G-Protein Signaling Pathways, Regulation of Actin Cytoskeleton, and Cardiovascular Signaling were found. Potential molecular targets linking RMG/photoreceptor interaction with the development of retinal telangiectasia are identified. This model can help us to better understand the physiopathologic mechanisms of MacTel 2 and other retinal diseases associated with telangiectasia.
Copyright © 2015 the authors 0270-6474/15/356093-14$15.00/0.

Entities:  

Keywords:  adherens junction; disease model; genetics; microcirculation; retinal blood vessels; retinal degeneration

Mesh:

Substances:

Year:  2015        PMID: 25878282      PMCID: PMC4397606          DOI: 10.1523/JNEUROSCI.3412-14.2015

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  50 in total

1.  The developmental expression of K+ channels in retinal glial cells is associated with a decrease of osmotic cell swelling.

Authors:  Antje Wurm; Thomas Pannicke; Ianors Iandiev; Peter Wiedemann; Andreas Reichenbach; Andreas Bringmann
Journal:  Glia       Date:  2006-10       Impact factor: 7.452

2.  Efficacy of anti-vascular endothelial growth factor therapy in subretinal neovascularization secondary to macular telangiectasia type 2.

Authors:  Raja Narayanan; Jay Chhablani; Manish Sinha; Vivek Dave; Mudit Tyagi; Rajeev R Pappuru; Baruch D Kuppermann
Journal:  Retina       Date:  2012 Nov-Dec       Impact factor: 4.256

3.  TGF-beta increases retinal endothelial cell permeability by increasing MMP-9: possible role of glial cells in endothelial barrier function.

Authors:  M A Behzadian; X L Wang; L J Windsor; N Ghaly; R B Caldwell
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-03       Impact factor: 4.799

4.  Monthly ranibizumab for nonproliferative macular telangiectasia type 2: a 12-month prospective study.

Authors:  Peter Charbel Issa; Robert P Finger; Kathrin Kruse; Sönke Baumüller; Hendrik P N Scholl; Frank G Holz
Journal:  Am J Ophthalmol       Date:  2011-02-19       Impact factor: 5.258

5.  The outer limiting membrane (OLM) revisited: clinical implications.

Authors:  S Omri; B Omri; M Savoldelli; L Jonet; B Thillaye-Goldenberg; G Thuret; P Gain; J C Jeanny; P Crisanti; Francine Behar-Cohen
Journal:  Clin Ophthalmol       Date:  2010-04-26

Review 6.  CRB1 mutation spectrum in inherited retinal dystrophies.

Authors:  Anneke I den Hollander; Jason Davis; Saskia D van der Velde-Visser; Marijke N Zonneveld; Chiara O Pierrottet; Robert K Koenekoop; Ulrich Kellner; L Ingeborgh van den Born; John R Heckenlively; Carel B Hoyng; Penny A Handford; Ronald Roepman; Frans P M Cremers
Journal:  Hum Mutat       Date:  2004-11       Impact factor: 4.878

7.  Correlation of functional impairment and morphological alterations in patients with group 2A idiopathic juxtafoveal retinal telangiectasia.

Authors:  Steffen Schmitz-Valckenberg; Kristie Fan; Alex Nugent; Gary S Rubin; Tunde Peto; Adnan Tufail; Cathy Egan; Alan C Bird; Fred W Fitzke
Journal:  Arch Ophthalmol       Date:  2008-03

8.  Regulation of vascular endothelial junction stability and remodeling through Rap1-Rasip1 signaling.

Authors:  Christopher W Wilson; Weilan Ye
Journal:  Cell Adh Migr       Date:  2014       Impact factor: 3.405

9.  The relationship between inner retinal cavitation, photoreceptor disruption, and the integrity of the outer limiting membrane in macular telangiectasia type 2.

Authors:  Meidong Zhu; Matthew Krilis; Mark C Gillies
Journal:  Retina       Date:  2013-09       Impact factor: 4.256

10.  Modulation of retinal capillary endothelial cells by Müller glial cell-derived factors.

Authors:  Hayato Abukawa; Masatoshi Tomi; Jumpei Kiyokawa; Satoko Hori; Tetsu Kondo; Tetsuya Terasaki; Ken-Ichi Hosoya
Journal:  Mol Vis       Date:  2009-02-27       Impact factor: 2.367

View more
  24 in total

1.  Genome-wide analyses identify common variants associated with macular telangiectasia type 2.

Authors:  Thomas S Scerri; Anna Quaglieri; Carolyn Cai; Jana Zernant; Nori Matsunami; Lisa Baird; Lea Scheppke; Roberto Bonelli; Lawrence A Yannuzzi; Martin Friedlander; Catherine A Egan; Marcus Fruttiger; Mark Leppert; Rando Allikmets; Melanie Bahlo
Journal:  Nat Genet       Date:  2017-02-27       Impact factor: 38.330

2.  Detailed electroretinographic findings in rd8 mice.

Authors:  Alan B Saul; Xuezhi Cui; Shanu Markand; Sylvia B Smith
Journal:  Doc Ophthalmol       Date:  2017-03-27       Impact factor: 2.379

3.  Dilated retinal large vessels and capillaries associated with diabetic macular edema and photoreceptor loss respectively.

Authors:  Jianqin Lei; Xiayu Xu; Li Chen; Xiaojuan Fan; Nizar Saleh Abdelfattah
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-01-08       Impact factor: 3.117

4.  CHARACTERISTICS OF PIGMENTED LESIONS IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA.

Authors:  Irene Leung; Ferenc B Sallo; Roberto Bonelli; Traci E Clemons; Daniel Pauleikhoff; Emily Y Chew; Alan C Bird; Tunde Peto
Journal:  Retina       Date:  2018-01       Impact factor: 4.256

5.  ABNORMAL RETINAL REFLECTIVITY TO SHORT-WAVELENGTH LIGHT IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA.

Authors:  Ferenc B Sallo; Irene Leung; Meike Zeimer; Traci E Clemons; Adam M Dubis; Marcus Fruttiger; Daniel Pauleikhoff; Emily Y Chew; Catherine Egan; Tunde Peto; Alan C Bird
Journal:  Retina       Date:  2018-01       Impact factor: 4.256

6.  Identification of Arhgef12 and Prkci as genetic modifiers of retinal dysplasia in the Crb1rd8 mouse model.

Authors:  Sonia M Weatherly; Gayle B Collin; Jeremy R Charette; Lisa Stone; Nattaya Damkham; Lillian F Hyde; James G Peterson; Wanda Hicks; Gregory W Carter; Jürgen K Naggert; Mark P Krebs; Patsy M Nishina
Journal:  PLoS Genet       Date:  2022-06-08       Impact factor: 6.020

Review 7.  Rat models of human diseases and related phenotypes: a systematic inventory of the causative genes.

Authors:  Claude Szpirer
Journal:  J Biomed Sci       Date:  2020-08-02       Impact factor: 8.410

8.  Zebrafish Crb1, Localizing Uniquely to the Cell Membranes around Cone Photoreceptor Axonemes, Alleviates Light Damage to Photoreceptors and Modulates Cones' Light Responsiveness.

Authors:  Chuanyu Guo; Ciana Deveau; Cen Zhang; Ralph Nelson; Xiangyun Wei
Journal:  J Neurosci       Date:  2020-08-14       Impact factor: 6.167

9.  CONCURRENT IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2 AND CENTRAL SEROUS CHORIORETINOPATHY.

Authors:  Alexandre Matet; Suzanne Yzer; Emily Y Chew; Alejandra Daruich; Francine Behar-Cohen; Richard F Spaide
Journal:  Retina       Date:  2018-01       Impact factor: 4.256

10.  Defining inclusion criteria and endpoints for clinical trials: a prospective cross-sectional study in CRB1-associated retinal dystrophies.

Authors:  Mays Talib; Mary J van Schooneveld; Jan Wijnholds; Maria M van Genderen; Nicoline E Schalij-Delfos; Herman E Talsma; Ralph J Florijn; Jacoline B Ten Brink; Frans P M Cremers; Alberta A H J Thiadens; L Ingeborgh van den Born; Carel B Hoyng; Magda A Meester-Smoor; Arthur A Bergen; Camiel J F Boon
Journal:  Acta Ophthalmol       Date:  2021-02-02       Impact factor: 3.761

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.